225 related articles for article (PubMed ID: 18582854)
1. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
Bosak A; Gazić I; Vinković V; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
3. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
4. Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.
Bosak A; Gazić Smilović I; Sinko G; Vinković V; Kovarik Z
J Med Chem; 2012 Aug; 55(15):6716-23. PubMed ID: 22817559
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.
Pistolozzi M; Du H; Wei H; Tan W
Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505
[TBL] [Abstract][Full Text] [Related]
6. Preparative HPLC separation of bambuterol enantiomers and stereoselective inhibition of human cholinesterases.
Gazić I; Bosak A; Sinko G; Vinković V; Kovarik Z
Anal Bioanal Chem; 2006 Aug; 385(8):1513-9. PubMed ID: 16865342
[TBL] [Abstract][Full Text] [Related]
7. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
9. Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.
Bosak A; Smilović IG; Stimac A; Vinković V; Sinko G; Kovarik Z
Arch Biochem Biophys; 2013 Jan; 529(2):140-5. PubMed ID: 23219600
[TBL] [Abstract][Full Text] [Related]
10. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
11. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline.
Kovarik Z; Simeon-Rudolf V
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):113-7. PubMed ID: 15449725
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
13. Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterases.
Calić M; Bosak A; Kuca K; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):305-8. PubMed ID: 18501885
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
15. Screening assays for cholinesterases resistant to inhibition by organophosphorus toxicants.
Wang Y; Schopfer LM; Duysen EG; Nachon F; Masson P; Lockridge O
Anal Biochem; 2004 Jun; 329(1):131-8. PubMed ID: 15136175
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
19. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
20. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
